A recent study evaluated the effectiveness, safety, and costs of using Patient Blood Management (PBM) to cope with blood shortages during the COVID-19 pandemic. This study found that PBM led to a reduction in blood transfusions, hospital stays, complications from transfusions, infections, and mortality, in addition to economic and financial benefits. This research supports the conclusion that PBM is an efficient, safe, and cost-effective practice that can reduce blood transfusions, improve clinical outcomes, and save resources; all of these characteristics helped the health system while it was strained by the pandemic. Read the full article here.